Bronchodilator responsiveness in wheezy infants and toddlers is not associated with asthma risk factors
dc.contributor.author | Debley, Jason | en_US |
dc.contributor.author | Stanojevic, Sanja | en_US |
dc.contributor.author | Filbrun, Amy G. | en_US |
dc.contributor.author | Subbarao, Padmaja | en_US |
dc.date.accessioned | 2012-05-21T15:49:36Z | |
dc.date.available | 2013-07-01T14:33:06Z | en_US |
dc.date.issued | 2012-05 | en_US |
dc.identifier.citation | Debley, Jason; Stanojevic, Sanja; Filbrun, Amy G.; Subbarao, Padmaja (2012). "Bronchodilator responsiveness in wheezy infants and toddlers is not associated with asthma risk factors." Pediatric Pulmonology 47(5): 421-428. <http://hdl.handle.net/2027.42/91214> | en_US |
dc.identifier.issn | 8755-6863 | en_US |
dc.identifier.issn | 1099-0496 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/91214 | |
dc.description.abstract | Background There are limited data assessing bronchodilator responsiveness (BDR) in infants and toddlers with recurrent wheezing, and factors associated with a positive response. Objectives In a multicenter study of children ≤ 36 months old, we assessed the prevalence of and factors associated with BDR among infants/toddlers with recurrent episodes of wheezing. Methods Forced expiratory flows and volumes using the raised‐volume rapid thoracic compression method were measured in 76 infants/toddlers [mean (SD) age 16.8 (7.6) months] with recurrent wheezing before and after administration of albuterol. Prior history of hospitalization or emergency department treatment for wheezing, use of inhaled or systemic corticosteroids, physician treatment of eczema, environmental tobacco smoke exposure, and family history of asthma or allergic rhinitis were ascertained. Results Using the published upper limit of normal for post bronchodilator change (FEV 0.5 ≥ 13% and/or FEF 25–75 ≥ 24%) in healthy infants, 24% (n = 18) of children in our study exhibited BDR. The BDR response was not associated with any clinical factor other than body size. Dichotomizing subjects into responders (defined by published limits of normal) or by quartile to identify children with the greatest change from baseline (4th quartile vs. other) did not identify any other factor associated with BDR. Conclusions Approximately one quarter of infants/toddlers with recurrent wheezing exhibited BDR at their clinical baseline. However, BDR in wheezy infants/toddlers was not associated with established clinical asthma risk factors. Pediatr Pulmonol. 2012; 47:421–428. © 2011 Wiley Periodicals, Inc. | en_US |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Infants | en_US |
dc.subject.other | Raised‐Volume Rapid Thoracoabdominal Compression | en_US |
dc.subject.other | Bronchodilator Responsiveness | en_US |
dc.subject.other | Asthma | en_US |
dc.subject.other | Recurrent Wheezing | en_US |
dc.subject.other | Pulmonary Function | en_US |
dc.title | Bronchodilator responsiveness in wheezy infants and toddlers is not associated with asthma risk factors | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pediatrics | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, Michigan, | en_US |
dc.contributor.affiliationother | Pulmonary Division (A‐5937), Seattle Children's Hospital, 4800 Sand Point Way NE, Seattle, WA, 98105. | en_US |
dc.contributor.affiliationother | Seattle Children's Hospital, University of Washington, Seattle, Washington, | en_US |
dc.contributor.affiliationother | Hospital for Sick Children, University of Toronto, Ontario, Canada | en_US |
dc.identifier.pmid | 22006677 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/91214/1/21567_ftp.pdf | |
dc.identifier.doi | 10.1002/ppul.21567 | en_US |
dc.identifier.source | Pediatric Pulmonology | en_US |
dc.identifier.citedreference | Castro‐Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000; 162: 1403 – 1406. | en_US |
dc.identifier.citedreference | Modl M, Eber E, Weinhandl E, Gruber W, Zach MS. Assessment of bronchodilator responsiveness in infants with bronchiolitis. A comparison of the tidal and the raised volume rapid thoracoabdominal compression technique. Am J Respir Crit Care Med 2000; 161: 763 – 768. | en_US |
dc.identifier.citedreference | Hayden MJ, Wildhaber JH, LeSouef PN. Bronchodilator responsiveness testing using raised volume forced expiration in recurrently wheezing infants. Pediatr Pulmonol 1998; 26: 35 – 41. | en_US |
dc.identifier.citedreference | Jones M, Castile R, Davis S, Kisling J, Filbrun D, Flucke R, Goldstein A, Emsley C, Ambrosius W, Tepper RS. Forced expiratory flows and volumes in infants. Normative data and lung growth. Am J Respir Crit Care Med 2000; 161: 353 – 359. | en_US |
dc.identifier.citedreference | Goldstein AB, Castile RG, Davis SD, Filbrun DA, Flucke RL, McCoy KS, Tepper RS. Bronchodilator responsiveness in normal infants and young children. Am J Respir Crit Care Med 2001; 164: 447 – 454. | en_US |
dc.identifier.citedreference | Saito J, Harris WT, Gelfond J, Noah TL, Leigh MW, Johnson R, Davis SD. Physiologic, bronchoscopic, and bronchoalveolar lavage fluid findings in young children with recurrent wheeze and cough. Pediatr Pulmonol 2006; 41: 709 – 719. | en_US |
dc.identifier.citedreference | ATS/ERS statement: raised volume forced expirations in infants: guidelines for current practice. Am J Respir Crit Care Med 2005; 172: 1463 – 1471. | en_US |
dc.identifier.citedreference | de Onis M, Onyango AW, Borghi E, Garza C, Yang H. Comparison of the World Health Organization (WHO) Child Growth Standards and the National Center for Health Statistics/WHO international growth reference: implications for child health programmes. Public Health Nutr 2006; 9: 942 – 947. | en_US |
dc.identifier.citedreference | Bussamra MH, Cukier A, Stelmach R, Rodrigues JC. Evaluation of the magnitude of the bronchodilator response in children and adolescents with asthma. Chest 2005; 127: 530 – 535. | en_US |
dc.identifier.citedreference | Galant SP, Morphew T, Amaro S, Liao O. Value of the bronchodilator response in assessing controller naive asthmatic children. J Pediatr 2007; 151: 457 – 462, 462 e451. | en_US |
dc.identifier.citedreference | Galant SP, Morphew T, Newcomb RL, Hioe K, Guijon O, Liao O. The relationship of the bronchodilator response phenotype to poor asthma control in children with normal spirometry. J Pediatr 2011; 158: 953 – 959.e1. | en_US |
dc.identifier.citedreference | Sharma S, Litonjua AA, Tantisira KG, Fuhlbrigge AL, Szefler SJ, Strunk RC, Zeiger RS, Murphy AJ, Weiss ST. Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program. J Allergy Clin Immunol 2008; 122: 921 – 928, e924. | en_US |
dc.identifier.citedreference | Kerstjens HA, Overbeek SE, Schouten JP, Brand PL, Postma DS. Airways hyperresponsiveness, bronchodilator response, allergy and smoking predict improvement in FEV1 during long‐term inhaled corticosteroid treatment. Dutch CNSLD Study Group. Eur Respir J 1993; 6: 868 – 876. | en_US |
dc.identifier.citedreference | Martin RJ, Szefler SJ, King TS, Kraft M, Boushey HA, Chinchilli VM, Craig TJ, Dimango EA, Deykin A, Fahy JV, et al. The predicting response to inhaled corticosteroid efficacy (PRICE) trial. J Allergy Clin Immunol 2007; 119: 73 – 80. | en_US |
dc.identifier.citedreference | Zielen S, Christmann M, Kloska M, Dogan‐Yildiz G, Lieb A, Rosewich M, Schubert R, Rose MA, Schulze J. Predicting short term response to anti‐inflammatory therapy in young children with asthma. Curr Med Res Opin 2010; 26: 483 – 492. | en_US |
dc.identifier.citedreference | van Grunsven PM, van Schayck CP, Molema J, Akkermans RP, van Weel C. Effect of inhaled corticosteroids on bronchial responsiveness in patients with “corticosteroid naive” mild asthma: a meta‐analysis. Thorax 1999; 54: 316 – 322. | en_US |
dc.identifier.citedreference | Saglani S, Malmstrom K, Pelkonen AS, Malmberg LP, Lindahl H, Kajosaari M, Turpeinen M, Rogers AV, Payne DN, Bush A, et al. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med 2005; 171: 722 – 727. | en_US |
dc.identifier.citedreference | Modl M, Eber E, Malle‐Scheid D, Weinhandl E, Zach MS. Does bronchodilator responsiveness in infants with bronchiolitis depend on age? J Pediatr 2005; 147: 617 – 621. | en_US |
dc.identifier.citedreference | Debley JS, Stamey DC, Cochrane ES, Gama KL, Redding GJ. Exhaled nitric oxide, lung function, and exacerbations in wheezy infants and toddlers. J Allergy Clin Immunol 2010; 125: 1228 – 1234, e1213. | en_US |
dc.identifier.citedreference | Debley JSS, Cochrane E, Elliot M, Redding G. Exhaled nitric oxide predicts persistence of wheezing, exacerbations, and decline in lung function in wheezy infants and toddlers. Am J Respir Crit Care Med 2011; 183: A1033. | en_US |
dc.identifier.citedreference | Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995; 332: 133 – 138. | en_US |
dc.identifier.citedreference | Yao W, Barbe‐Tuana FM, Llapur CJ, Jones MH, Tiller C, Kimmel R, Kisling J, Nguyen ET, Nguyen J, Yu Z, et al. Evaluation of airway reactivity and immune characteristics as risk factors for wheezing early in life. J Allergy Clin Immunol 2010; 126: 483 – 488, e481. | en_US |
dc.identifier.citedreference | Palmer LJ, Rye PJ, Gibson NA, Burton PR, Landau LI, Lesouef PN. Airway responsiveness in early infancy predicts asthma, lung function, and respiratory symptoms by school age. Am J Respir Crit Care Med 2001; 163: 37 – 42. | en_US |
dc.identifier.citedreference | Cunningham J, Dockery DW, Speizer FE. Maternal smoking during pregnancy as a predictor of lung function in children. Am J Epidemiol 1994; 139: 1139 – 1152. | en_US |
dc.identifier.citedreference | Li YF, Gilliland FD, Berhane K, McConnell R, Gauderman WJ, Rappaport EB, Peters JM. Effects of in utero and environmental tobacco smoke exposure on lung function in boys and girls with and without asthma. Am J Respir Crit Care Med 2000; 162: 2097 – 2104. | en_US |
dc.identifier.citedreference | Gilliland FD, Berhane K, Li YF, Rappaport EB, Peters JM. Effects of early onset asthma and in utero exposure to maternal smoking on childhood lung function. Am J Respir Crit Care Med 2003; 167: 917 – 924. | en_US |
dc.identifier.citedreference | Moshammer H, Hoek G, Luttmann‐Gibson H, Neuberger MA, Antova T, Gehring U, Hruba F, Pattenden S, Rudnai P, Slachtova H, et al. Parental smoking and lung function in children: an international study. Am J Respir Crit Care Med 2006; 173: 1255 – 1263. | en_US |
dc.identifier.citedreference | Martinez FD. Development of wheezing disorders and asthma in preschool children. Pediatrics 2002; 109: 362 – 367. | en_US |
dc.identifier.citedreference | Morton RL, Sheikh S, Corbett ML, Eid NS. Evaluation of the wheezy infant. Ann Allergy Asthma Immunol 2001; 86: 251 – 256. | en_US |
dc.identifier.citedreference | Guerra S, Lohman IC, Halonen M, Martinez FD, Wright AL. Reduced interferon gamma production and soluble CD14 levels in early life predict recurrent wheezing by 1 year of age. Am J Respir Crit Care Med 2004; 169: 70 – 76. | en_US |
dc.identifier.citedreference | NIH/NHLBI. National Asthma Education and Prevention Program Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. | en_US |
dc.identifier.citedreference | Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2010. Available from: http://www.ginasthma.org/Guidelines/guidelines‐resources.html | en_US |
dc.identifier.citedreference | Beardsmore CS, Page C, Silverman M. The response to beta‐agonists in wheezy infants: three methods compared. Respir Med 2004; 98: 1138 – 1145. | en_US |
dc.identifier.citedreference | Feher A, Castile R, Kisling J, Angelicchio C, Filbrun D, Flucke R, Tepper R. Flow limitation in normal infants: a new method for forced expiratory maneuvers from raised lung volumes. J Appl Physiol 1996; 80: 2019 – 2025. | en_US |
dc.identifier.citedreference | Turner DJ, Lanteri CJ, LeSouef PN, Sly PD. Improved detection of abnormal respiratory function using forced expiration from raised lung volume in infants with cystic fibrosis. Eur Respir J 1994; 7: 1995 – 1999. | en_US |
dc.identifier.citedreference | Turner DJ, Stick SM, Lesouef KL, Sly PD, Lesouef PN. A new technique to generate and assess forced expiration from raised lung volume in infants. Am J Respir Crit Care Med 1995; 151: 1441 – 1450. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.